npj Vaccines is an open access, peer-reviewed journal dedicated to publishing high-quality research on all aspects of vaccine development, delivery, and impact. First 150 characters: Open access journal focusing on vaccine research, development, and impact, covering basic science to clinical applications and public health considerations.
It encompasses a wide array of subjects including vaccine design, preclinical and clinical trials, immunogenicity studies, vaccine safety, and vaccine policy. npj Vaccines is part of the Nature Partner Journals series and is indexed in databases such as PubMed Central and Scopus. Its target audience includes vaccinologists, immunologists, public health officials, and researchers in related fields.
By offering a platform for the rapid dissemination of important findings, npj Vaccines aims to accelerate the development and deployment of effective vaccines to address global health challenges. Visit the journal's website for comprehensive submission guidelines and information, promoting high-quality and impactful research.